Injective Foundation is stepping out of its early trajectory once centered on derivatives trading into a broader role as a multi-chain finance infrastructure layer. The latest announcement of its EVM mainnet launch opens up the network to a wider builder base. Ethereum developers can now deploy familiar Solidity contracts without needing bridges or middleware, marking a meaningful shift in accessibility and ecosystem scale.
Complementing that is Injective’s latest no-code toolset, “iBuild,” which empowers creators, studios and even non-technical teams to craft on-chain financial applications, from prediction markets to tokenised private assets. The strategy is clear: democratise access and invite a wider spectrum of builders into Injective’s architecture. Meanwhile, the protocol has expanded into derivatives tied to private companies like SpaceX and OpenAI, aiming to attract capital beyond the crypto native market and draw a deeper connection to real-world finance.
From a token-economics perspective the INJ token remains under pressure. Unlock schedules still loom and token release velocity will affect sentiment unless matched by substantial usage and staking demand. The value capture model hinges on whether the infrastructure actually gets used at scale by developers, institutions and large liquidity flows rather than only by traders.
The next six to twelve months will matter. Injective’s competitive edge lies in its focus on finance first: offering native derivatives, tokenised assets and infrastructure tailored to institutional workflows. If the ecosystem begins to produce volume, vaults and real-world integrations, Injective could transition from niche to foundational. If not, it risks remaining a derivatives-centric chain in a crowded field of alternatives.
